In addition, the expression of fibronectin and αSMA, collagen content, and smad2 activation were significantly higher in the BLM-KO group than in the BLM-WT group, suggesting a protective role of Meflin in anti-fibrotic effects against lung fibrosis (Nakahara et al., 2021). The gene discussed is FN1; the disease is Bloom syndrome.